制药公司Regeneron因第二季度业绩向好而股价上涨

路透中文
Jul 30
BUZZ-制药公司Regeneron因第二季度业绩向好而股价上涨

7月30日 - ** 制药公司Regeneron Pharmaceuticals(REGN.O)盘前股价上涨5%,至730.26美元,此前该公司公布的第二季度业绩超出市场预期 (link)

** 得益于抗炎药物Dupixent和眼科药物Eylea销售额的增长,公司第二季度利润实现增长

** 该公司连续第五个季度盈利超出分析师预期——路孚斯集团(LSEG)数据显示

** 根据路孚斯集团(LSEG)汇总的数据,Regeneron第二季度调整后每股收益(EPS)为14.3美元,高于分析师预期的10.3美元

** 公司第二季度营收同比增长17%至42.9亿美元,高于38.2亿美元的预期

** 截至上一交易日收盘,REGN股价年内累计下跌9.9%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10